The Utility of Retinol-Binding Protein 4 in Predicting Liver Fibrosis in Chronic Hepatitis C Patients in Response to Direct-Acting Antivirals

References

• Castera L. Non-invasive assessment of liver fibrosis in chronic hepatitis C. Hepatol Int. 2011;5:625–634. doi:10.1007/s12072-010-9240-0
   PubMed Web of Science ®Google Scholar
• Petta S, Camma C, Di Marco V, et al. Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1. Hepatology. 2008;48:28–37. doi:10.1002/hep.v48:1
   PubMed Web of Science ®Google Scholar
• Chen CH, Lin ST, Kuo CL, et al. Clinical significance of elevated alpha-fetoprotein (AFP) chronic hepatitis C without hepatocellular carcinoma. Hepatogastroenterology. 2008;55:1423–1427.
   PubMed Web of Science ®Google Scholar
• Tacke F, Trautwein C. Mechanisms of liver fibrosis resolution. J Hepatol. 2015;63:1038–1039. doi:10.1016/j.jhep.2015.03.039
   PubMed Web of Science ®Google Scholar
• European Association for Study of Liver. EASL recommendations on treatment of hepatitis C 2015. J Hepatol. 2015;63:199–236. doi:10.1016/j.jhep.2015.03.025
   PubMed Web of Science ®Google Scholar
• Peng Y, Qi X, Guo X. Child-pugh versus MELD score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Medicine (Baltimore). 2016;95(8):e2877. doi:10.1097/MD.0000000000002877
   PubMed Web of Science ®Google Scholar
• Shiha G, Seif S, Maher M, et al. Comparison between Transient Elastography (FibroScan) and liver biopsy for the diagnosis of hepatic fibrosis in chronic hepatitis C patients. MJVH. 2016;2(1):17–25.
   Google Scholar
• Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518–526. doi:10.1053/jhep.2003.50346
   PubMed Web of Science ®Google Scholar
• Bonacini M, Hadi G, Govindarajan S, et al. Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 1997;92(8):1302–1304.
   Web of Science ®Google Scholar
• Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibro test. Hepatology. 2007;46:32–36. doi:10.1002/(ISSN)1527-3350
   PubMed Web of Science ®Google Scholar
• Islam S, Antonsson L, Westin J, et al. Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers. Scand J Gastroenterol. 2005;40:867–872. doi:10.1080/00365520510015674
   PubMed Web of Science ®Google Scholar
• Lok AS, Ghany MG, Goodman ZD, et al. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology. 2005;42:282–292. doi:10.1002/hep.20772
   PubMed Web of Science ®Google Scholar
• Zampino R, Marrone A, Restivo L, et al. Chronic HCV infection and inflammation: clinical impact on hepatic and extra-hepatic manifestations. World J Hepatol. 2013;5(10):528–540. doi:10.4254/wjh.v5.i10.528
   PubMedGoogle Scholar
• Azzazi MO, Mohamed MA, Mousa MM, et al. Multicentre study of hepatitis C virus status in Egyptian patients with B-cell non-Hodgkin’s lymphoma with assessment of patients’ immunological state. Egypt J Haematol. 2017;42:19–30. doi:10.4103/1110-1067.206435
   Web of Science ®Google Scholar
• Miller FD, Abu-Raddad LJ. Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proc Natl Acad Sci USA. 2009;107:14757–14762. doi:10.1073/pnas.1008877107
   Web of Science ®Google Scholar
• Allam A, Gabr S, Ajarem J, et al. Bcl-2 and p53 expression in hepatic tissues of Egyptian patients with chronic hepatitis C. J Pak Med Assoc. 2015;65(11):1186–1192.
   Web of Science ®Google Scholar
• Goldstein NS, Blue DE, Hankin R, et al. Serum alpha-fetoprotein levels in patients with chronic hepatitis C. Relationship with serum alanine aminotransferase values, histologic activity index, and hepatocyte MIB-1 scores. Am J Clin Pathol. 1999;111:811–816. doi:10.1093/ajcp/111.6.811
   Web of Science ®Google Scholar
• Alsebaey A, Elhelbawy M, Waked I. Platelets-to-lymphocyte ratio is a good predictor of liver fibrosis and insulin resistance in hepatitis C virus-related liver disease. Eur J Gastroenterol Hepatol. 2018;30(2):207–211. doi:10.1097/MEG.0000000000001013
   PubMed Web of Science ®Google Scholar
• He Q, He Q, Qin X, et al. The relationship between inflammatory marker levels and hepatitis C virus severity. Gastroenterol Res Pract. 2016;2016:2978479. doi:10.1155/2016/2978479
   Web of Science ®Google Scholar
• Meng X, Wei G, Chang Q, et al. The platelet-to-lymphocyte ratio, superior to the neutrophil-to-lymphocyte ratio, correlates with hepatitis C virus infection. Int J Infect Dis. 2016;45:72–77. doi:10.1016/j.ijid.2016.02.025
   Web of Science ®Google Scholar
• Miyaki E, Imamura M, Hiraga N, et al. Daclatasvir and asunaprevir treatment improves liver function parameters and reduces liver fibrosis markers in chronic hepatitis C patients. Hepatol Res. 2016;46:758–764. doi:10.1111/hepr.v46.8
   PubMed Web of Science ®Google Scholar
• Ripoche J. Blood platelets and inflammation: their relationship with liver and digestive diseases. Clin Res Hepatol Gastroenterol. 2011;35:353–357. doi:10.1016/j.clinre.2011.02.012
   PubMed Web of Science ®Google Scholar
• Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005;41:48–54. doi:10.1002/hep.20506
   PubMed Web of Science ®Google Scholar
• Castera L, Pinzani M, Bosch J. Noninvasive evaluation of portal hypertension using transient elastography. J Hepatol. 2012;56:696–703. doi:10.1016/j.jhep.2011.07.005
   PubMed Web of Science ®Google Scholar
• Friedrich-Rust M, Ong MF, Martens S, et al. Performance of transient Elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology. 2008;134:960–974. doi:10.1053/j.gastro.2008.01.034
   PubMed Web of Science ®Google Scholar
• Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128:343–350. doi:10.1053/j.gastro.2004.11.018
   PubMed Web of Science ®Google Scholar
• Ogawa E, Furusyo N, Toyoda K, et al. The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon-alpha-2b and ribavirin. Antiviral Res. 2009;83:127–134. doi:10.1016/j.antiviral.2009.04.002
   PubMed Web of Science ®Google Scholar
• Snyder N, Gajula L, Xiao SY, et al. APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C. J Clin Gastroenterol. 2006;40:535–542. doi:10.1097/00004836-200607000-00013
   Web of Science ®Google Scholar
• Li SM, Li GX, Fu DM, et al. Liver fibrosis evaluation by ARFI and APRI in chronic hepatitis C. World J Gastroenterol. 2014;20:9528–9533. doi:10.3748/wjg.v20.i28.9528
   Web of Science ®Google Scholar
• Amorim TG, Staub GJ, Lazzarotto C, et al. Validation and comparison of simple, noninvasive models for the prediction of liver fibrosis in chronic hepatitis C. Ann Hepatol. 2012;11:855–861. doi:10.1016/S1665-2681(19)31410-3
   PubMed Web of Science ®Google Scholar
• Khan DA, Fatima-Tuz-Zuhra FA, Mubarak A. Evaluation of diagnostic accuracy of APRI for prediction of fibrosis in hepatitis C patients. J Ayub Med Coll Abbottabad. 2008;20:122–126.
   Google Scholar
• Baranova A, Lal P, Birerdinc A, et al. Noninvasive markers for hepatic fibrosis. BMC Gastroenterol. 2011;11:91. doi:10.1186/1471-230X-11-91
   PubMed Web of Science ®Google Scholar
• Derbala M, Elbadri ME, Amer AM, et al. Aspartate transaminase to platelet ratio index in hepatitis C virus and Schistosomiasis coinfection. World J Gastroenterol. 2015;21(46):13132–13139. doi:10.3748/wjg.v21.i46.13132
   Web of Science ®Google Scholar
• Adler M, Gulbis B, Moreno C, et al. The predictive value of FIB-4 versus FibroTest, APRI. Fibro Index and Forns index to noninvasively estimate fibrosis in hepatitis C and non-hepatitis C liver diseases. Hepatology. 2008;47(2):762–763. doi:10.1002/hep.22085
   Web of Science ®Google Scholar
• Fouad SA, Esmat S, Omran D, et al. Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection. World J Gastroenterol. 2012;18(23):2988–2994. doi:10.3748/wjg.v18.i23.2988
   Web of Science ®Google Scholar
• Bayati N, Silverman AL, Gordon SC. Serum alpha-fetoprotein levels and liver histology in patients with chronic hepatitis C. Am J Gastroenterol. 1998;93:2452–2456. doi:10.1111/ajg.1998.93.issue-12
   PubMed Web of Science ®Google Scholar
• Chu CW, Hwang SJ, Luo JC, et al. Clinical, virologic, and pathologic significance of elevated serum alpha-fetoprotein levels in patients with chronic hepatitis C. J Clin Gastroenterol. 2001;2:240–244. doi:10.1097/00004836-200103000-00014
   Web of Science ®Google Scholar
• Di Bisceglie AM, Sterling RK, Chung RT, et al. Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial. J Hepatol. 2005;43(3):434–441. doi:10.1016/j.jhep.2005.03.019
   PubMed Web of Science ®Google Scholar
• Nguyen K, Jimenez M, Moghadam N, et al. Decrease of alpha-fetoprotein in patients with cirrhosis treated with direct-acting antivirals. J Clin Transl Hepatol. 2017;5(1):43–49. doi:10.14218/JCTH.2016.00057
   PubMed Web of Science ®Google Scholar
• Tachi Y, Hirai T, Ishizu Y, et al. α-fetoprotein levels after interferon therapy predict regression of liver fibrosis in patients with sustained virological response. J Gastroenterol Hepatol. 2016;31:1001–1008. doi:10.1111/jgh.13245
   Web of Science ®Google Scholar
• Takayama K, Furusyo N, Ogawa E, et al. Direct-acting antiviral-based triple therapy on alpha-fetoprotein level in chronic hepatitis C patients. World J Gastroenterol. 2015;21:4696–4706. doi:10.3748/wjg.v21.i15.4696
   Web of Science ®Google Scholar
• Tai WC, Hu TH, Wang JH, et al. Clinical implications of alpha-fetoprotein in chronic hepatitis C. J Formos Med Assoc. 2009;108(3):210–218. doi:10.1016/S0929-6646(09)60054-1
   PubMed Web of Science ®Google Scholar
• Huang JF, Dai CY, Yu ML, et al. Serum retinol binding protein 4 is inversely correlated with disease severity of chronic hepatitis C. J Hepatol. 2009;50(3):471–478. doi:10.1016/j.jhep.2008.10.023
   PubMed Web of Science ®Google Scholar
• Kataria Y, Deaton RJ, Enk E, et al. Retinoid and carotenoid status in serum and liver among patients at high-risk for liver cancer. BMC Gastroenterol. 2016;16:30. doi:10.1186/s12876-016-0432-5
   PubMed Web of Science ®Google Scholar
• Kwon JH, Park ST, Kim GD, et al. The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease. Korean J Hepatol. 2008;15:59–69. doi:10.3350/kjhep.2009.15.1.59
   Google Scholar
• Peres WA, Chaves GV, JCS G, et al. Vitamin A deficiency in patients with hepatitis C virus-related chronic liver disease. Br J Nutr. 2011;106(11):1724–1731. doi:10.1017/S0007114511002145
   Web of Science ®Google Scholar
• Wang L, Attard FA, Tankersley LR, et al. Effect of retinoic acid on the enhancing effect of acetaldehyde on mouse type I collagen expression. Arch Biochem Biophys. 2000;376(1):191–198. doi:10.1006/abbi.2000.1723
   Web of Science ®Google Scholar
• Gruys E, Toussaint MJM, Niewold TA, et al. Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci B. 2005;6(11):1045–1056. doi:10.1631/jzus.2005.B1045
   PubMedGoogle Scholar
• Boursier J, Vergniol J, Sawadogo A, et al. The combination of a blood test and fibroscan improves the non-invasive diagnosis of liver fibrosis. Liver Int. 2009;29:1507–1515. doi:10.1111/liv.2009.29.issue-10
   PubMed Web of Science ®Google Scholar
• Poynard T, Ingiliz P, Elkrief L, et al. Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers. PLoS One. 2008;3:e3857. doi:10.1371/journal.pone.0003857
   Web of Science ®Google Scholar
• Sebastiani G, Vario A, Guido M, et al. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol. 2006;44(4):686–693. doi:10.1016/j.jhep.2006.01.007
   Web of Science ®Google Scholar